Status:
UNKNOWN
Enteral Nutrition Product in Mild Acute Pancreatitis
Lead Sponsor:
Vegenat, S.A.
Conditions:
Acute Pancreatitis
Enteral Nutrition
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The aim of the study is to evaluate the beneficial effects of the administration of enteral nutrition product with milk proteins, monounsaturated fatty acids and low dextrose equivalent maltodextrin a...
Detailed Description
Oral administration of an oligomeric formula with milk proteins, mainly whey protein partially hydrolysate, monounsaturated fatty acids (AGM) and low dextrose equivalent maltodextrin and enriched in p...
Eligibility Criteria
Inclusion
- Patients over 18 with Mild Acute Pancreatitis.
Exclusion
- Patients with Several Acute Pancreatitis
- Patients with life expectancy less than 48 hours.
- Renal (creatinin \> 2,5 mg/dl) or kidney failure (GOT/GPT\>2 from laboratory normal value)
- Patients with diabetes mellitus prior to acute pancreatitis.
- To take part in another study.
- Pregnant patients
- Informed consent absence.
Key Trial Info
Start Date :
February 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2013
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT01249963
Start Date
February 1 2011
End Date
March 1 2013
Last Update
June 22 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Clinical Nutrition and Dietetic Unit, Hospital Universitario Gregorio Marañón
Madrid, Madrid, Spain, 28007